In accordance with the ICH GCP Guideline, prior to initiating a trial, which of the following should define, establish, and allocate all…

According to the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) Guideline E6(R2), the sponsor is ultimately responsible for implementing and maintaining quality assurance and quality control systems. This includes defining, establishing, and allocating all trial-related duties and functions prior to the trial's initiation. While a sponsor may transfer any or all of these duties to a Contract Research Organization (CRO), the transfer must be specified in writing. However, the ultimate responsibility for the quality and integrity of the trial data always resides with the sponsor. This ensures a clear and documented assignment of responsibilities before any trial activities commence.

A. The institutional administrator: Manages institutional resources and provides administrative oversight, but does not define or allocate specific trial-related duties per ICH GCP.

C. The study coordinator: Works under the investigator's supervision to perform delegated tasks at the site level, not to define and allocate all trial functions.

D. The IRB/IEC: Is responsible for the ethical review of the trial and protection of human subjects, not the operational management or allocation of duties.

1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2016). Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Section 5.7, "Allocation of Duties and Functions," p. 21.

2. Harvard Catalyst | The Harvard Clinical and Translational Science Center. (n.d.). Good Clinical Practice (GCP) Course: Roles and Responsibilities. Module 2, "Sponsor Responsibilities." Retrieved from https://catalyst.harvard.edu/courses/gcp/ (Note: Specific courseware content may require login, but the public-facing curriculum outlines these standard GCP principles).

3. Tenti, E., Simonetti, G., & Tassinari, D. (2021). Good Clinical Practice: The sponsor's and the investigator's point of view. European Journal of Internal Medicine, 89, 1-5. https://doi.org/10.1016/j.ejim.2021.05.020 (This article discusses the distinct responsibilities of the sponsor as outlined in ICH GCP, including the allocation of duties).